GlassScriptPhysician profile
Ambooj Tiwari
NPI 1609198779
$2,173.29
in general payments reported to CMS, 2019-2025
21 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2021: $34.06 · 2022: $214 · 2023: $536 · 2024: $211 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $468.10 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Stryker Corporation | $249.02 | 2019 | |
| Penumbra, INC. | $245.12 | 2019-2023 | Red 72 |
| Eisai INC. | $213.16 | 2023-2025 | |
| Medtronic USA, INC. | $163.40 | 2019 | |
| Octapharma USA, INC. | $144.74 | 2023-2025 | Balfaxar, Panzyga, Fibryga |
| Amgen INC. | $125.00 | 2025 | |
| Sk Life Science, INC. | $108.88 | 2023-2024 | |
| Pfizer INC. | $95.90 | 2023-2025 | |
| Medtronic, INC. | $69.17 | 2021-2022 | |
| Argenx US, INC. | $47.39 | 2023 | Vyvgart |
| Angiodynamics, INC. | $32.07 | 2025 | Smart Port Ct |
| Abbvie INC. | $31.93 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $31.51 | 2025 | |
| Neurocrine Biosciences, INC. | $27.75 | 2024 | Ingrezza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $27.24 | 2019 | |
| Amneal Pharmaceuticals LLC | $21.31 | 2023 | Rytary |
| Depuy Synthes Sales INC. | $20.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.69 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $17.36 | 2023 | Rexulti |
| Asahi Intecc USA, INC. | $16.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ambooj Tiwari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.